Anadys Pharmaceuticals, Inc - Financial and Strategic Analysis Review

Summary

Anadys Pharmaceuticals, Inc - Financial and Strategic Analysis Review

Anadys Pharmaceuticals, Inc. (Anadys) is a Clinical Stage biopharmaceutical company that develops novel therapeutics for the treatment of chronic hepatitis C viral infections and cancer. The company is in development stage without any commercialized products. It generates revenue from collaboration agreements of product development and commercialization with many pharmaceutical companies. It focuses on research and development of three products including two products for the diagnosis of hepatitis C and one product for cancer. The company is headquartered in San Diego in California, United States

Global Markets Direct's Anadys Pharmaceuticals, Inc - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Anadys Pharmaceuticals, Inc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • Anadys Pharmaceuticals, Inc - Key Facts
  • Anadys Pharmaceuticals, Inc - Business Description
  • Anadys Pharmaceuticals, Inc - Major Products and Services
  • Anadys Pharmaceuticals, Inc - History
  • Anadys Pharmaceuticals, Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Anadys Pharmaceuticals, Inc - Strengths
  • Strength - Focused research and development activities
  • Strength - Strong Liquidity Position
  • Anadys Pharmaceuticals, Inc - Weaknesses
  • Weakness - History of Operating Losses
  • Weakness - Lack of internal manufacturing capabilities
  • Anadys Pharmaceuticals, Inc - Opportunities
  • Opportunity - Therapeutic Focus
  • Opportunity - Growth in the Prevalence of Cancer
  • Opportunity - Biotech Focus
  • Opportunity - Rising Healthcare Expenditure in the US
  • Anadys Pharmaceuticals, Inc - Threats
  • Threat - Industry Consolidation
  • Threat - Tightening of FDA's Regulatory Oversight
  • Threat - Increased Pricing Control
  • Anadys Pharmaceuticals, Inc - Key Competitors
  • Anadys Pharmaceuticals, Inc - Key Employees
  • Anadys Pharmaceuticals, Inc - Key Employee Biographies
  • Anadys Pharmaceuticals, Inc - Locations And Subsidiaries
  • Head Office
  • Anadys Pharmaceuticals, Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Anadys Pharmaceuticals, Inc, Key Facts
  • Anadys Pharmaceuticals, Inc, Major Products and Services
  • Anadys Pharmaceuticals, Inc, History
  • Anadys Pharmaceuticals, Inc, Key Employees
  • Anadys Pharmaceuticals, Inc, Key Employee Biographies
  • Anadys Pharmaceuticals, Inc, Ratios based on current share price
  • Anadys Pharmaceuticals, Inc, Annual Ratios
  • Anadys Pharmaceuticals, Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • Anadys Pharmaceuticals, Inc, Ratio Charts